Novo agrees $2.6B deal for Hengrui’s preclinical GLP-1/GIP drug
Novo’s ongoing attempts to rejuvenate its pipeline have seen the Big Pharma turn to one of the most…
Browsing Tag
Licensing deals
1 post
Browsing Tag